136 related articles for article (PubMed ID: 17621525)
1. No kinetic interaction between levetiracetam and cyclosporine: a case report.
Franzoni E; Sarajlija J; Garone C; Malaspina E; Marchiani V
J Child Neurol; 2007 Apr; 22(4):440-2. PubMed ID: 17621525
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
3. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
Krief P; Li Kan ; Maytal J
J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
[TBL] [Abstract][Full Text] [Related]
5. Rapid dosage titration of levetiracetam in children.
Vaisleib II; Neft RA
Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
[TBL] [Abstract][Full Text] [Related]
6. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy.
Harbord MG
J Paediatr Child Health; 2011 May; 47(5):302-4. PubMed ID: 21244554
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
[TBL] [Abstract][Full Text] [Related]
10. Use of levetiracetam in treating epilepsy associated with other medical conditions.
Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam in absence epilepsy.
Verrotti A; Cerminara C; Domizio S; Mohn A; Franzoni E; Coppola G; Zamponi N; Parisi P; Iannetti P; Curatolo P
Dev Med Child Neurol; 2008 Nov; 50(11):850-3. PubMed ID: 18808424
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam for seizures in children with brain tumors and other cancers.
Partap S; Fisher PG
Pediatr Blood Cancer; 2009 Feb; 52(2):288-9. PubMed ID: 18831033
[TBL] [Abstract][Full Text] [Related]
14. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
Friedman D; French JA
Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
Di Bonaventura C; Fattouch J; Mari F; Egeo G; Vaudano AE; Prencipe M; Manfredi M; Giallonardo AT
Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
[TBL] [Abstract][Full Text] [Related]
16. Intravenous levetiracetam in children with epilepsy.
Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
[TBL] [Abstract][Full Text] [Related]
17. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Donato Di Paola E; Gareri P; Davoli A; Gratteri S; Scicchitano F; Naccari C; De Sarro G
Epilepsy Res; 2007 Jul; 75(2-3):112-21. PubMed ID: 17553669
[TBL] [Abstract][Full Text] [Related]
18. Thrombocytopenia as an adverse effect of levetiracetam therapy in a child.
Peer Mohamed B; Prabhakar P
Neuropediatrics; 2009 Oct; 40(5):243-4. PubMed ID: 20221962
[TBL] [Abstract][Full Text] [Related]
19. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
Szucs A; Clemens Z; Jakus R; Rásonyi G; Fabó D; Holló A; Barcs G; Kelemen A; Janszky J
Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam monotherapy for late poststroke seizures in the elderly.
Kutlu G; Gomceli YB; Unal Y; Inan LE
Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
